Title: Director, Value Evidence Generation (HEOR), Hematology
Location: Edison, NJ/Remote
If you are interested in the below position, please send your resume to [email protected] and REFERENCE THE POSITION TITLE within the subject line.
As a member of the TG Therapeutics Value Evidence Generation team, the Director of Value of Evidence Generation will lead the strategy and tactical efforts to address Health Economics and Outcomes Research (HEOR)-related drivers and barriers to market access for Hematology disease area. S/he will assess evidence needs and lead relevant strategic evidence generation and develop the product value propositions and messaging. This role will report to the Executive Director, Head of Value Evidence Generation, and will reside within the Value, Policy and Advocacy organization. This role will also require cross-functional collaboration across departments such as Clinical Development, Medical Affairs, Brand, Market Access and multiple other functions.
––Evaluate and synthesize the existing evidence base for the indications of interest, inclusive of unmet need, burden of disease and core evidence for potential comparators in support of the assigned pipeline compounds to inventory existing supporting data and identify data and knowledge gaps
––Collaboratively work with the development team and commercial colleagues to hypothesize the potential value messages that could be planned for the assigned products. Prioritize key value areas of interest and proactively plan for and execute evidence generation to substantiate these value hypotheses
––Support and lead the design, execution and analysis of HEOR strategies and tactics to support the value propositions of the assigned compounds
––Design, conduct, and deliver studies, analyses and FDAMA 114 tools to demonstrate product value (e.g. prospective and retrospective observational studies, indirect treatment comparisons, patient reported outcomes study, cost effectiveness and budget impact models).
––Recommend and prioritize model and indirect comparisons study data requirements which may be addressed through clinical trials and evidence generation activities and work with clinical team to provide input on endpoint structure of clinical trials
––Lead the development of Academy of Managed Care Pharmacy (AMCP) formulary submission dossiers; assist Value, Policy and Advocacy leaders with ICER and other payer influential bodies
––Engage with health economics opinion leaders and external clinical advisors; seek their guidance, validation, and support on various HEOR studies
––Partner with Medical Affairs and Clinical Development colleagues to prepare conference presentations, manuscripts, and other communications
––Build/ adapt content and data for submission to health insurers and payment authorities
––5+ years relevant HEOR experience required; prior pharmaceutical industry experience required; prior managed care experience preferred.
––Experience in hematology preferred but not required
––Strong technical expertise required in design and conduct of HEOR studies and models in support of oncology therapeutic area; experience in product launch is a plus
––Experience in design, implementation, conduct and analysis of prospective and retrospective observational studies, real world data analyses, patient reported outcomes, indirect comparisons study, cost effectiveness and budget impact models
––Strong publication track record in HEOR area with focus in oncology is desirable
––Highly effective written and verbal communication skills
––Strong organizational skills
––Ability to anticipate and solve problems
––Strong work ethic with an ability to adapt quickly
• Willingness and ability to travel domestically and internationally, as required.
Advanced graduate degree (Ph.D., MS, or MD, PharmD., B.Pharm with Master’s degree) in HEOR-related field (e.g. pharmacoepidemiology, epidemiology, healthcare/data analytics, health economics, health services research, public health).